09:48 EDT SilverBck Ther. trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SPRY:
- ARS Pharma (NASDAQ:SPRY) Plummets on FDA Snub for Epinephrine Nasal Spray
- ARS Pharmaceuticals issued CRL by FDA for neffy NDA, plans to appeal
- ARS downgraded to Market Perform from Outperform at William Blair
- FDA Issues Complete Response Letter for neffy® (epinephrine nasal spray) New Drug Application with Request for Additional Study
- ARS Reports Second Quarter 2023 Financial Results and Provides Business Updates
Questions or Comments about the article? Write to editor@tipranks.com